333 related articles for article (PubMed ID: 16387104)
1. Renal anemia aggravated by long-term parvovirus B19 and cytomegalovirus infection in a renal transplant patient: case report and evaluation of B19 seroprevalence in dialysis patients.
Becker MR; Schneider B; Reber U; Pöge U; Klein B; Klehr HU; Zhou H; Fischer HP; Eis-Hübinger AM
Transplant Proc; 2005 Dec; 37(10):4306-8. PubMed ID: 16387104
[TBL] [Abstract][Full Text] [Related]
2. Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3.
Liefeldt L; Plentz A; Klempa B; Kershaw O; Endres AS; Raab U; Neumayer HH; Meisel H; Modrow S
J Med Virol; 2005 Jan; 75(1):161-9. PubMed ID: 15543575
[TBL] [Abstract][Full Text] [Related]
3. Transient aplastic anemia caused by parvovirus B19 infection in a heart transplant recipient.
Bergen GA; Sakalosky PE; Sinnott JT
J Heart Lung Transplant; 1996 Aug; 15(8):843-5. PubMed ID: 8878766
[TBL] [Abstract][Full Text] [Related]
4. [Seroprevalence of parvovirus B19 in patients with chronic idiopathic thrombocytopenic purpura].
Uslu H; Kiki I; Ozbek A; Erdem F; Ayyildiz A
Mikrobiyol Bul; 2007 Oct; 41(4):597-602. PubMed ID: 18173080
[TBL] [Abstract][Full Text] [Related]
5. Clinical implications of quantitative real time-polymerase chain reaction of parvovirus B19 in kidney transplant recipients - a prospective study.
Park JB; Kim DJ; Woo SY; Choi GS; Chun JM; Jung GO; Kwon CH; Kim SJ; Joh JW; Lee SK
Transpl Int; 2009 Apr; 22(4):455-62. PubMed ID: 19144091
[TBL] [Abstract][Full Text] [Related]
6. Human parvovirus B19 in patients with aplastic anemia.
Mishra B; Malhotra P; Ratho RK; Singh MP; Varma S; Varma N
Am J Hematol; 2005 Jun; 79(2):166-7. PubMed ID: 15929106
[TBL] [Abstract][Full Text] [Related]
7. Recurrent anemia in kidney transplant recipients with parvovirus B19 infection.
Renoult E; Bachelet C; Krier-Coudert MJ; Diarrassouba A; André JL; Kessler M
Transplant Proc; 2006 Sep; 38(7):2321-3. PubMed ID: 16980079
[TBL] [Abstract][Full Text] [Related]
8. Parvovirus B19 infection causing red cell aplasia in renal transplantation on tacrolimus.
Wong TY; Chan PK; Leung CB; Szeto CC; Tam JS; Li PK
Am J Kidney Dis; 1999 Dec; 34(6):1132-6. PubMed ID: 10585325
[TBL] [Abstract][Full Text] [Related]
9. [Research on Parvovirus B19 infections and chronic articular manifestations in a Tunisian hospital].
Regaya F; Khelifa R; Zouari R; Kchir M; Karoui M; Essid R
Arch Inst Pasteur Tunis; 2003; 80(1-4):9-15. PubMed ID: 15941063
[TBL] [Abstract][Full Text] [Related]
10. The association of pityriasis rosea with cytomegalovirus, Epstein-Barr virus and parvovirus B19 infections - a prospective case control study by polymerase chain reaction and serology.
Chuh AA
Eur J Dermatol; 2003; 13(1):25-8. PubMed ID: 12609777
[TBL] [Abstract][Full Text] [Related]
11. Long-term remission of recurrent parvovirus-B associated anemia in a renal transplant recipient induced by treatment with immunoglobulin and positive seroconversion.
Kumar J; Shaver MJ; Abul-Ezz S
Transpl Infect Dis; 2005 Mar; 7(1):30-3. PubMed ID: 15984946
[TBL] [Abstract][Full Text] [Related]
12. [Parvovirus B19 infection after renal transplantation].
Rerolle JP; Helal I; Morelon E
Nephrologie; 2003; 24(6):309-15. PubMed ID: 14584298
[TBL] [Abstract][Full Text] [Related]
13. Incidence and clinical significance of human parvovirus B19 infection in kidney transplant recipients.
Ki CS; Kim IS; Kim JW; Lee NY; Kim SH; Lee KW; Kim SJ; Joh JW; Huh WS; Oh HY
Clin Transplant; 2005 Dec; 19(6):751-5. PubMed ID: 16313320
[TBL] [Abstract][Full Text] [Related]
14. Parvovirus B19 infections in patients with chronic anemia.
Heegaard ED; Myhre J; Hornsleth A; Gundestrup M; Boye H
Haematologica; 1997; 82(4):402-5. PubMed ID: 9299850
[TBL] [Abstract][Full Text] [Related]
15. Low-level DNAemia of parvovirus B19 (genotypes 1-3) in adult transplant recipients is not associated with anaemia.
Plentz A; Würdinger M; Kudlich M; Modrow S
J Clin Virol; 2013 Oct; 58(2):443-8. PubMed ID: 23916377
[TBL] [Abstract][Full Text] [Related]
16. Effects of transfusion on human erythrovirus B19-susceptible or -infected pediatric recipients in a genotype 3-endemic area.
Parsyan A; Addo-Yobo E; Owusu-Ofori S; Akpene H; Sarkodie F; Allain JP
Transfusion; 2006 Sep; 46(9):1593-600. PubMed ID: 16965589
[TBL] [Abstract][Full Text] [Related]
17. Parvovirus B19 infection contributes to severe anemia in young children in Papua New Guinea.
Wildig J; Michon P; Siba P; Mellombo M; Ura A; Mueller I; Cossart Y
J Infect Dis; 2006 Jul; 194(2):146-53. PubMed ID: 16779719
[TBL] [Abstract][Full Text] [Related]
18. Parvovirus b19 infection in HIV patient with pure red cell aplasia.
Sanphasitvong W; Poovorawan K; Boonsuk P; Assanasen T; Na Nakorn T; Poovorawan Y
Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1216-20. PubMed ID: 16438148
[TBL] [Abstract][Full Text] [Related]
19. Severe parvovirus B19 encephalitis after renal transplantation.
Laurenz M; Winkelmann B; Roigas J; Zimmering M; Querfeld U; Müller D
Pediatr Transplant; 2006 Dec; 10(8):978-81. PubMed ID: 17096771
[TBL] [Abstract][Full Text] [Related]
20. Parvovirus B19-induced anemia in renal transplantation: a role for rHuEPO in resistance to classical treatment.
Arzouk N; Snanoudj R; Beauchamp-Nicoud A; Mourad G; Charpentier B; Tchernia G; Durrbach A
Transpl Int; 2006 Feb; 19(2):166-9. PubMed ID: 16441366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
